Euronav announces first quarter 2018 results
Apr 25, 2018 06:01 am UTC| Business
HIGHLIGHTS Difficult and challenging freight market remains in place Recycling of ships rise offset by concentrated delivery schedule current tonnage oversupply Balance sheet strength retained with substantial...
HPR Extends High-Performance Capital Markets Infrastructure Platform into Europe
Apr 25, 2018 06:00 am UTC| Business
PARIS (TRADETECH EUROPE), April 25, 2018 -- Hyannis Port Research (HPR), provider of advanced capital markets infrastructure (CMI) technologies, today announced that a leading global investment bank has gone live on the...
VPN.com & Michael Gargiulo Accepted into Forbes Technology Council
Apr 25, 2018 06:00 am UTC| Business
NEW YORK and ATLANTA, April 25, 2018 -- Michael Gargiulo, founder of VPN.com—the worldwide leader in Virtual Private Network (VPN) research and statistics—has been accepted into the Forbes Technology Council. This...
Nicox: :Opening of U.S. Development Office in Research Triangle Park, North Carolina
Apr 25, 2018 05:31 am UTC| Business
Press Release Nicox: Opening of U.S. Development Office in Research Triangle Park, North Carolina Company to relocate its growing U.S. development operations to the North Carolina biotech hub in Research Triangle...
STMicroelectronics Reports 2018 First Quarter Financial Results
Apr 25, 2018 05:02 am UTC| Business
PR No. C2848C STMicroelectronics Reports 2018 First Quarter Financial Results Net revenues of $2.23 billion, up 22.2% year-over-year Gross and operating margins up significantly year-over-year to 39.9% and...
Norsk Hydro: First quarter 2018: Results up on higher prices, higher raw material costs
Apr 25, 2018 05:02 am UTC| Business
Hydro's underlying earnings before financial items and tax increased to NOK 3,147 million in the first quarter, up from NOK 2,284 million for same quarter last year. The increase mainly reflects a higher all-in metal price...
Targovax presentation at ChinaBio Partnering Forum 2018
Apr 25, 2018 05:01 am UTC| Business
Oslo, Norway, 25 April 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumours, have today presented at the ChinaBio Partnering Forum 2018. ...